A carregar...
Product review on the monoclonal antibody palivizumab for prevention of respiratory syncytial virus infection
Respiratory syncytial virus (RSV) accounts for about 20% of all respiratory infections in children below the age of 5 y. It is associated with up to 63% of all acute respiratory infections and up to 81% of all viral lower respiratory tract infections causing hospitalization in infants and young chil...
Na minha lista:
| Publicado no: | Hum Vaccin Immunother |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5612471/ https://ncbi.nlm.nih.gov/pubmed/28605249 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2017.1337614 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|